Copyright
©The Author(s) 2004.
World J Gastroenterol. Jan 15, 2004; 10(2): 295-298
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.295
Published online Jan 15, 2004. doi: 10.3748/wjg.v10.i2.295
n | CD3+ | CD4+ | CD8+ | CD4+/CD8+ | NK | ||
reated group | BT | 36 | 47.14 ± 4.76 | 41.56 ± 5.06 | 30.10 ± 3.03 | 1.41 ± 0.24 | 43.62 ± 5.92 |
AT | 36 | 57.81 ± 5.83 | 54.81 ± 5.64ab | 23.07 ± 4.47ab | 2.49 ± 0.72ab | 56.69 ± 5.29ab | |
Control group | BT | 14 | 39.93 ± 5.00 | 28.38 ± 3.40 | 23.38 ± 3.40 | 1.40 ± 0.18 | 40.36 ± 5.90 |
AT | 14 | 52.28 ± 7.18b | 29.17 ± 1.86 | 29.17 ± 1.86 | 1.34 ± 0.88 | 59.40 ± 4.97b |
- Citation: Zhang CP, Tian ZB, Liu XS, Zhao QX, Wu J, Liang YX. Effects of zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis. World J Gastroenterol 2004; 10(2): 295-298
- URL: https://www.wjgnet.com/1007-9327/full/v10/i2/295.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i2.295